VANGUARD GROUP INC: PTRN position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of VANGUARD GROUP INC on PTRN, newest first. How the timeline and the estimate are built.
VANGUARD GROUP INC held 3,912,896 PTRN shares at 2026-06-30 per its 13F-HR filed 2026-08-13.
the latest 13F is the newest step
- period ended2026-06-3013F 3,912,896 sharesChange vs previous 13F +1,952,056 shares
<0.01% of the 13F portfolio, value $98,565,851.
13F-HR 0002100121-26-001018 filed by VANGUARD PORTFOLIO MANAGEMENT LLC
Filed (acceptance time not in the bulk data set), ingested- VANGUARD FIDUCIARY TRUST CO: 221,443 shares
- Vanguard Investments Australia, Ltd.: 7,879 shares
- VANGUARD ASSET MANAGEMENT, Ltd: 23,078 shares
- Vanguard Global Advisers, LLC: 11,251 shares
- VANGUARD CAPITAL MANAGEMENT LLC: 1,612,146 shares
- VANGUARD PORTFOLIO MANAGEMENT LLC: 2,037,099 shares
Acceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F/A 1,960,840 sharesChange vs previous 13F +3,944 shares
<0.01% of the 13F portfolio, value $24,373,241.
13F-HR/A 0002100119-26-001311 filed by VANGUARD CAPITAL MANAGEMENT LLC
Filed (acceptance time not in the bulk data set), ingested- VANGUARD FIDUCIARY TRUST CO: 130,114 shares
- Vanguard Global Advisers, LLC: 8,670 shares
- VANGUARD CAPITAL MANAGEMENT LLC: 983,008 shares
- VANGUARD PORTFOLIO MANAGEMENT LLC: 839,048 shares
Acceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 1,956,896 sharesChange vs previous 13F +450,345 shares
<0.01% of the 13F portfolio, value $22,582,580.
13F-HR 0000102909-26-000031 filed by VANGUARD GROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,506,551 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $20,639,749.
13F-HR 0000102909-25-000353 filed by VANGUARD GROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).